Neuroprotection by a bradykinin B2 receptor antagonist after traumatic brain injury is not attenuated by the simultaneous application of a bradykinin B1 receptor antagonist

被引：0
|
作者：
Görlach, C
Hortobágyi, T
Hortobágyi, S
Benyó, Z
Relton, JK
Whalley, ET
Wahl, M
机构：
[1] Univ Munich, Dept Physiol, D-8000 Munich, Germany
[2] Semmelweis Univ, Dept Expt Res, Inst Physiol 2, H-1085 Budapest, Hungary
[3] Biogen Inc, Cambridge, MA 02142 USA
来源：
JOURNAL OF PHYSIOLOGY-LONDON | 2000年 / 526卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：50P / 51P
页数：2
相关论文
共 50 条
  • [1] Analogues of bradykinin B2 receptor antagonist
    Sobolewski, Dariusz
    Neugebauer, Witold
    Cote, Jerome
    Belanger, Simon
    Gobeil, Jr. Fernand
    Lammek, Bernard
    Prahl, Adam
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 96 - 96
  • [2] Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury
    Görlach, C
    Hortobágyi, T
    Hortobágyi, S
    Benyó, Z
    Relton, J
    Whalley, ET
    Wahl, M
    JOURNAL OF NEUROTRAUMA, 2001, 18 (08) : 833 - 838
  • [3] The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
    Haleema Shakur
    Peter Andrews
    Toomas Asser
    Laura Balica
    Cristian Boeriu
    Juan Diego Ciro Quintero
    Yashbir Dewan
    Patrick Druwé
    Olivia Fletcher
    Chris Frost
    Bennie Hartzenberg
    Jorge Mejia Mantilla
    Francisco Murillo-Cabezas
    Jan Pachl
    Ramalingam R Ravi
    Indrek Rätsep
    Cristina Sampaio
    Manmohan Singh
    Petr Svoboda
    Ian Roberts
    Trials, 10
  • [4] The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
    Shakur, Haleema
    Andrews, Peter
    Asser, Toomas
    Balica, Laura
    Boeriu, Cristian
    Ciro Quintero, Juan Diego
    Dewan, Yashbir
    Druwe, Patrick
    Fletcher, Olivia
    Frost, Chris
    Hartzenberg, Bennie
    Mejia Mantilla, Jorge
    Murillo-Cabezas, Francisco
    Pachl, Jan
    Ravi, Ramalingam R.
    Raetsep, Indrek
    Sampaio, Cristina
    Singh, Manmohan
    Svoboda, Petr
    Roberts, Ian
    TRIALS, 2009, 10
  • [5] Neuroprotection of bradykinin/bradykinin B2 receptor system in cerebral ischemia
    Ji, Bingyuan
    Cheng, Baohua
    Pan, Yanyou
    Wang, Chunmei
    Chen, Jing
    Bai, Bo
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 94 : 1057 - 1063
  • [6] Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema
    Austinat, Madeleine
    Braeuninger, Stefan
    Pesquero, Joao B.
    Brede, Marc
    Bader, Michael
    Stoll, Guido
    Renne, Thomas
    Kleinschnitz, Christoph
    STROKE, 2009, 40 (01) : 285 - 293
  • [7] Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
    Vincent F Simmon
    Trials, 10
  • [8] Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection from Cerebral Infarction and Brain Edema
    Kleinschnitz, Christoph
    Braeuninger, Stefan
    Bader, Lwichael
    Renne, Thomas
    Stoll, Guido
    NEUROLOGY, 2009, 72 (11) : A121 - A121
  • [9] Effects of the bradykinin B2 receptor antagonist Icatibant on microvascular permeability after thermal injury in sheep
    Jonkam, Collette C.
    Enkhbaatar, Perenlei
    Nakano, Yoshimitsu
    Boehm, Thomas
    Wang, Jianpu
    Nussberger, Juerg
    Esechie, Aimalohi
    Traber, Lillian D.
    Herndon, David
    Traber, Daniel L.
    SHOCK, 2007, 28 (06): : 704 - 709
  • [10] Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
    Simmon, Vincent F.
    TRIALS, 2009, 10
12345